Mode
Text Size
Log in / Sign up

Delayed intervention in acute decompensated aortic stenosis shows no significant long-term mortality differenceTiming of valve surgery for aortic stenosis shows mixed results

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that delayed intervention in acute decompensated aortic stenosis is not significantly associated with long-term mortality.

This meta-analysis included 6044 patients with acute decompensated aortic stenosis to evaluate the impact of time to valve intervention, including transcatheter aortic valve replacement (TAVR) or balloon aortic valvuloplasty (BAV). The study compared delayed versus earlier intervention on mortality outcomes.

Primary results indicated that long-term all-cause mortality was not significantly associated with delayed intervention (HR 1.52; 95% CI 0.46-5.00; p=0.269). Mortality per five-day delay also did not show a significant association (HR 1.09; 95% CI 0.34-3.43; p=0.530). Conversely, short-term mortality was higher in the delayed intervention group (RR 4.96; 95% CI 1.17-20.92; p=0.029).

Several limitations affect the certainty of these findings, including a high risk of bias in most included studies and substantial heterogeneity in clinical severity, intervention timing, and treatment modality. Additionally, the association between delayed intervention and short-term mortality was not robust to sensitivity analyses. Current observational data do not establish a mortality benefit for a specific door-to-valve interval.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap regarding the timing of intervention in acute decompensated aortic stenosis. While previous coverage noted that TAV-in-TAV shows lower transvalvular gradients but no significant mortality difference compared to TAV-in-SAV, this study specifically examines the impact of the door-to-valve interval. It does not directly relate to findings on red blood cell transfusion, cerebral embolic protection, dapagliflozin use in frail patients, or pre-dilatation balloon aortic valvuloplasty.

When a patient has acute decompensated aortic stenosis, their heart is struggling to pump blood because of a narrowed valve. Doctors must decide how quickly to perform a procedure, like a transcatheter aortic valve replacement (TAVR), to open that valve. This study looked at whether waiting a few days to perform the surgery changed the long-term survival of over 6,000 patients.

The data showed that a delay in the procedure did not have a statistically significant impact on long-term mortality. However, there was a notable increase in short-term mortality for those whose procedures were delayed. This means that while the long-term outlook might stay the same, the immediate risk of death could be higher if the surgery is postponed.

It is important to note that these findings come from observational data, which shows patterns rather than direct cause and effect. The study also faced challenges like high variability in how patients were treated and a risk of bias in the original reports. Because of these factors, the evidence is currently not strong enough to set a specific rule for the best time to operate.

What this means for you:
Delayed surgery for aortic stenosis may increase short-term risk but does not clearly change long-term survival.

Common questions

Does delaying the surgery affect long-term survival?

The study of 6,044 patients found that a delayed intervention was not significantly associated with long-term all-cause mortality. While the data showed a higher risk for some, the results were not statistically significant, meaning the evidence is not strong enough to say for certain that timing changes long-term outcomes.

Is there a risk if the procedure is delayed by a few days?

The data showed a higher risk of short-term mortality for patients whose procedures were delayed. However, this specific finding was not robust when researchers performed sensitivity analyses. Because the data is based on observations rather than a controlled trial, talk to your doctor about the best timing for your specific case.

How certain are these findings about surgery timing?

The certainty of these results is low. The researchers noted that many studies had a risk of bias and there was a lot of variation in how patients were treated and when they received their procedures. These factors make it hard to establish a definitive rule for the best time to operate.

Study Details

Study typeRct
Sample sizen = 6,044
EvidenceLevel 2
PublishedNov 2026
View Original Abstract ↓
Background: Acute decompensated aortic stenosis (ADAS) carries high mortality, but the optimal timing of valve intervention is unknown. Objective: To assess the association between time to valve intervention (transcatheter aortic valve replacement [TAVR] or balloon aortic valvuloplasty [BAV]) and clinical outcomes in ADAS. Methods: Embase, Ovid MEDLINE and CENTRAL were searched to May 15, 2026. Hazard ratios (HRs) for delayed versus earlier intervention were pooled using random-effects models with modified Hartung-Knapp inference. Unadjusted short-term mortality risk ratios (RRs) were pooled using the Mantel-Haenszel method. Results: Eight observational cohort studies (n=6,044) met inclusion criteria: six TAVR (n= 5,986) and two BAV (n=58) studies. Patients were approximately 79 years old, and 63% were male. Early-intervention thresholds ranged from <24-48 hours (BAV) to ?22 days (TAVR) from admission. Delayed intervention was not significantly associated with long-term all-cause mortality (HR 1.52, 95% CI 0.46-5.00; p=0.269; I2=58.2%) or mortality per five-day delay (HR 1.09, 95% CI 0.34-3.43; p=0.530; I2=86.7%). Crude short-term mortality was higher with delayed intervention (RR 4.96, 95% CI 1.17-20.92; p=0.029; I2=0.0%), although this association was not robust to sensitivity analyses. Most studies were at serious risk of bias, with substantial heterogeneity in clinical severity, intervention timing, and treatment modality. Conclusion: Point estimates favour earlier intervention, but current observational data do not establish a mortality benefit for an optimal door-to-valve interval, and existing study designs are biased against early treatment. Prospective and randomized-controlled trials on optimal valve intervention timing following ADAS are needed.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.